Oncoclínicas (B3: ONCO3) stock: the official figures
Oncoclínicas (Oncoclínicas do Brasil Serviços Médicos S.A.) is listed on B3, the São Paulo stock exchange, under the ticker ONCO3. In fiscal 2025 it reported revenue of BRL 5,739m and a net loss of BRL 3,624m, according to the annual accounts it filed with the regulator.
Identifiers for Oncoclínicas: CNPJ 12.104.241/0004-02.
Fiscal 2025 figures
| Item | 2025 | 2024 | Change |
|---|---|---|---|
| Revenue | BRL 5,739m | BRL 6,227m | −7.8% |
| Operating profit | −BRL 1,990m | −BRL 119.9m | — |
| Net profit | −BRL 3,624m | −BRL 646.2m | — |
| Operating margin | −34.7% | −1.9% | −32.8 pts |
| Net margin | −63.1% | −10.4% | −52.8 pts |
| Total assets | BRL 7,131m | BRL 11,202m | −36.3% |
| Equity | BRL 900.9m | BRL 3,146m | −71.4% |
| Cash | BRL 509.5m | BRL 550.7m | −7.5% |
| Operating cash flow | −BRL 118.6m | −BRL 184.9m | — |
Margins are calculated from the filed figures: operating profit and net profit over revenue.
6 fiscal years
| Fiscal year | Revenue | Operating profit | Net profit | Document |
|---|---|---|---|---|
| 2025 | BRL 5,739m | −BRL 1,990m | −BRL 3,624m | Annual report |
| 2024 | BRL 6,227m | −BRL 119.9m | −BRL 646.2m | Annual report |
| 2023 | BRL 5,489m | BRL 758.0m | BRL 223.6m | Annual report |
| 2022 | BRL 4,088m | BRL 470.6m | BRL 46.3m | Annual report |
| 2021 | BRL 2,702m | BRL 177.2m | −BRL 46.9m | Annual report |
| 2020 | BRL 2,035m | BRL 19.6m | −BRL 159.6m | Annual report |
The full income statement, balance sheet and cash flow statement are in the annual accounts of Oncoclínicas. Year by year: revenue, net income and dividends paid.
Dividends
In fiscal 2025, Oncoclínicas paid BRL 36.8m in dividends, according to its cash flow statement.
| Fiscal year | Dividends paid | Share of net profit |
|---|---|---|
| 2025 | BRL 36.8m | — |
| 2024 | BRL 11.7m | — |
| 2023 | BRL 59.7m | 26.7% |
| 2022 | BRL 18.3m | 39.5% |
| 2021 | BRL 26.4m | — |
| 2020 | BRL 45.2m | — |
Cash paid out as dividends during the fiscal year, including dividends to minority shareholders of subsidiaries when the company does not report them separately. It is not the dividend per share.
Frequently asked questions about Oncoclínicas
- How much did Oncoclínicas earn in fiscal 2025?
- Oncoclínicas reported a net loss of BRL 3,624m for fiscal 2025, on revenue of BRL 5,739m. The year before it reported a net loss of BRL 646.2m.
- Does Oncoclínicas pay a dividend?
- In fiscal 2025, Oncoclínicas paid BRL 36.8m in dividends, according to its cash flow statement.
- Where is Oncoclínicas listed?
- Oncoclínicas is listed on B3, the São Paulo stock exchange, under the ticker ONCO3.
- Where do the figures for Oncoclínicas come from?
- From the annual financial statements (DFP) that Oncoclínicas files with the CVM, the Brazilian securities regulator. Each fiscal year links to its filing.
Where each figure comes from
The annual accounts come from the annual financial statements (DFP) that Oncoclínicas files with the CVM, the Brazilian securities regulator. Each fiscal year in the table links to its filing. Celsmar reads the tagged figures from the document and does not adjust them: if an item is not in the filing, it is not shown. More detail in data sources and, if you spot an error, in corrections. What Celsmar is and what it costs, in its fact sheet.
More companies from Brazil and the rest of the region: Latin American stocks.
Information prepared from the accounts the company files with the regulator, for information purposes only. It is not financial advice or a recommendation to buy or sell. Updated on 12 November 2026.